Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
mPathix Health is a U.S. healthcare company focused on developing, producing, and distributing multimodal pain-management and central nervous system-related solutions. The company has been described as a clinical-stage business and operates as a wholly owned subsidiary of Qualis Innovations, which later changed its corporate name to Family Office of America. Public descriptions emphasize therapeutic-device and modality-agnostic pain solutions rather than a disclosed, drug-like pipeline with named molecular assets. Available public information suggests mPathix is oriented toward pain-management product development and commercialization support rather than a broad traditional biotech pipeline. The company appears to be private at the operating-subsidiary level, with its parent historically associated with the OTC public market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on mPathix Health.